There are 142 resources available
78P - Electronic tool for high grade Adverse Event (AE) reporting in gynecology (gyne) clinical trials (ClinT) at Princess Margaret Cancer Centre (PM)
Presenter: Ainhoa Madariaga Urrutia
Session: Poster Display session
79P - The situation of gynecological cancer before and after COVID - 19 pandemic years in Kosovo
Presenter: Brunilda Profka
Session: Poster Display session
80P - Efficacy, FDA approval, innovativeness, clinical evidence, and price of breast, ovarian, endometrial, and cervical cancer drugs
Presenter: Julia Caroline Michaeli
Session: Poster Display session
32O - 5-year (y) overall survival (OS) with maintenance olaparib (ola) plus bevacizumab (bev) by clinical risk in patients (pts) with newly diagnosed advanced ovarian cancer (AOC) in the Phase III PAOLA-1/ENGOT-ov25 trial
Presenter: Domenica Lorusso
Session: Proffered Paper session
Resources:
Abstract
Slides
Webcast
33O - PRIMA/ENGOT-OV26/GOG-3012 study: long-term conditional PFS
Presenter: Antonio Jose Gonzalez Martin
Session: Proffered Paper session
Resources:
Abstract
Slides
Webcast
Invited Discussant of abstracts 32O and 33O
Presenter: Kathleen Moore
Session: Proffered Paper session
Resources:
Slides
Webcast
34O - ATR inhibitor alone (ceralasertib) or in combination with olaparib in gynaecological cancers with ARID1A loss or no loss - results from the ENGOT/GYN1/NCRI ATARI trial
Presenter: Susana Banerjee
Session: Proffered Paper session
Resources:
Abstract
Slides
Webcast
Invited Discussant of abstract 34O
Presenter: Jean Emmanuel Kurtz
Session: Proffered Paper session
Resources:
Slides
Webcast
35O - Overall Survival of Niraparib with Individualized Starting Dose as Maintenance Therapy in Patients with Platinum-Sensitive Recurrent Ovarian Cancer Adjusted for Subsequent PARPi Use in Placebo Group: Results from an Ad Hoc Interim Analysis for the Phase 3 NORA Study
Presenter: Xiaohua Wu
Session: Proffered Paper session
Resources:
Abstract
Slides
Webcast
Invited Discussant of abstract 35O
Presenter: Jonathan Ledermann
Session: Proffered Paper session
Resources:
Slides
Webcast